Skip to main content
Erschienen in: Journal of General Internal Medicine 11/2015

01.11.2015 | Original Research

Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans

verfasst von: Corrine I. Voils, PhD, Cynthia J. Coffman, PhD, Janet M. Grubber, MSPH, David Edelman, MD, MHS, Azita Sadeghpour, Ph.D., MS, Matthew L. Maciejewski, PhD, Jamiyla Bolton, MS, Alex Cho, MD, MBA, Geoffrey S. Ginsburg, MD, PhD, William S. Yancy Jr., MD, MHS

Erschienen in: Journal of General Internal Medicine | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

We examined the clinical utility of supplementing type 2 diabetes mellitus (DM) risk counseling with DM genetic test results and counseling.

Research Design and Methods

In this randomized controlled trial, non-diabetic overweight/obese veteran outpatients aged 21 to 65 years received DM risk estimates for lifetime risk, family history, and fasting plasma glucose, followed by either genetic test results (CR+G; N = 303) or control eye disease counseling (CR+EYE; N = 298). All participants received brief lifestyle counseling encouraging weight loss to reduce the risk of DM.

Results

The mean age was 54 years, 53% of participants were black, and 80% were men. There was no difference between arms in weight (estimated mean difference between CR+G vs. CR+EYE at 3 months = 0.2 kg, 95% CI: −0.3 to 0.7; at 6 months = 0.4 kg, 95 % CI: −0.3 to 1.1), insulin resistance, perceived risk, or physical activity at 3 or 6 months. Calorie and fat intake were lower in the CR+G arm at 3 months (p’s ≤ 0.05) but not at 6 months (p’s > 0.20).

Conclusions

Providing patients with genetic test results was not more effective in changing patient behavior to reduce the risk of DM compared to conventional risk counseling.
Trial registration: ClinicalTrials.gov NCT01060540 http://​clinicaltrials.​gov/​show/​NCT01060540
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Adriaanse MC, Snoek FJ, Dekker JM, et al. Perceived risk for Type 2 diabetes in participants in a stepwise population-screening programme. Diabet Med. 2003;20:210–215.CrossRefPubMed Adriaanse MC, Snoek FJ, Dekker JM, et al. Perceived risk for Type 2 diabetes in participants in a stepwise population-screening programme. Diabet Med. 2003;20:210–215.CrossRefPubMed
2.
Zurück zum Zitat Wee H-L, Cheung Y-B, Li S-C, Fong K-Y, Thumboo J. The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: Is the whole greater than the sum of its parts? Health Qual Life Outcome. 2005;3:2.CrossRef Wee H-L, Cheung Y-B, Li S-C, Fong K-Y, Thumboo J. The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: Is the whole greater than the sum of its parts? Health Qual Life Outcome. 2005;3:2.CrossRef
3.
Zurück zum Zitat Engelgau MM, Geiss LS, Saaddine JB, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140:945–950.CrossRefPubMed Engelgau MM, Geiss LS, Saaddine JB, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140:945–950.CrossRefPubMed
4.
Zurück zum Zitat Centers for Disease Control and Prevention: National Diabetes Fact Sheet, 2011, Fact Sheet. Atlanta, GA: Department of Health and Human Services - Center for Disease Control and Prevention, 2011. Centers for Disease Control and Prevention: National Diabetes Fact Sheet, 2011, Fact Sheet. Atlanta, GA: Department of Health and Human Services - Center for Disease Control and Prevention, 2011.
5.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.CrossRefPubMed Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.CrossRefPubMed
6.
Zurück zum Zitat Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29:2102–2107.PubMedCentralCrossRefPubMed Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29:2102–2107.PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–1686.CrossRefPubMed Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–1686.CrossRefPubMed
8.
9.
Zurück zum Zitat Weinstein N. What does it mean to understand a risk? Evaluation risk comprehension. J Natl Cancer Inst Monogr. 1999;25:15–12.CrossRefPubMed Weinstein N. What does it mean to understand a risk? Evaluation risk comprehension. J Natl Cancer Inst Monogr. 1999;25:15–12.CrossRefPubMed
10.
Zurück zum Zitat Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981–990.PubMedCentralCrossRefPubMed Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981–990.PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Hivert MF, Jablonski KA, Perreault L, et al. Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes. 2011;60:1340–1348.PubMedCentralCrossRefPubMed Hivert MF, Jablonski KA, Perreault L, et al. Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes. 2011;60:1340–1348.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006;355:241–250.PubMedCentralCrossRefPubMed Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006;355:241–250.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Voils CI, Coffman CJ, Edelman D, et al. Examining the impact of genetic testing for type 2 diabetes on health behaviors: Study protocol for a randomized controlled trial. Trials. 2012;13:121.PubMedCentralCrossRefPubMed Voils CI, Coffman CJ, Edelman D, et al. Examining the impact of genetic testing for type 2 diabetes on health behaviors: Study protocol for a randomized controlled trial. Trials. 2012;13:121.PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–1395.CrossRefPubMed Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–1395.CrossRefPubMed
15.
Zurück zum Zitat Block G: Block Brief 2000 Questionnaire, 2000. Block G: Block Brief 2000 Questionnaire, 2000.
16.
Zurück zum Zitat Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30:1562–1566.CrossRefPubMed Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30:1562–1566.CrossRefPubMed
17.
Zurück zum Zitat Hariri S, Yoon P, Qureshi N, et al. Family history of type 2 diabetes: A population-based screening tool for prevention? Genet Med. 2006;8:102–108.CrossRefPubMed Hariri S, Yoon P, Qureshi N, et al. Family history of type 2 diabetes: A population-based screening tool for prevention? Genet Med. 2006;8:102–108.CrossRefPubMed
18.
Zurück zum Zitat Weedon MN, McCarthy MI, Hitman G, et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 2006;3:e374.PubMedCentralCrossRefPubMed Weedon MN, McCarthy MI, Hitman G, et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 2006;3:e374.PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Fagerlin A, Zikmund-Fisher B, Ubel PA. Helping patients decide: Ten steps to better risk communication. J Natl Cancer Inst. 2011;103:1–8.CrossRef Fagerlin A, Zikmund-Fisher B, Ubel PA. Helping patients decide: Ten steps to better risk communication. J Natl Cancer Inst. 2011;103:1–8.CrossRef
21.
22.
Zurück zum Zitat US Department of Health and Human Services: 2008 Physical Activity Guidelines for Americans, 2008. US Department of Health and Human Services: 2008 Physical Activity Guidelines for Americans, 2008.
23.
Zurück zum Zitat Kahwati LC, Lance TX, Jones KR, Kinsinger LS. RE-AIM evaluation of the Veterans Health Administration’s MOVE! weight management program. Transl Behav Med. 2011;1:551–560. Kahwati LC, Lance TX, Jones KR, Kinsinger LS. RE-AIM evaluation of the Veterans Health Administration’s MOVE! weight management program. Transl Behav Med. 2011;1:551–560.
24.
Zurück zum Zitat Borm G, Fransen J, Lemmens W. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007;60:1234–1238.CrossRefPubMed Borm G, Fransen J, Lemmens W. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007;60:1234–1238.CrossRefPubMed
25.
Zurück zum Zitat Yancy W Jr, Westman E, McDuffie J, et al. A randomized trial of a low-carbohydrate, ketogenic diet versus orlistat plus a low-fat diet for weight loss. Arch Intern Med. 2010;170:136–145.CrossRefPubMed Yancy W Jr, Westman E, McDuffie J, et al. A randomized trial of a low-carbohydrate, ketogenic diet versus orlistat plus a low-fat diet for weight loss. Arch Intern Med. 2010;170:136–145.CrossRefPubMed
26.
Zurück zum Zitat Lindstrom J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26:3230–3236.CrossRefPubMed Lindstrom J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26:3230–3236.CrossRefPubMed
27.
Zurück zum Zitat Group IEEW. ICH harmonised tripartite guideline-Statistical principles for clinical trials. Stat Med. 1999;18:1905–1942. Group IEEW. ICH harmonised tripartite guideline-Statistical principles for clinical trials. Stat Med. 1999;18:1905–1942.
28.
Zurück zum Zitat Verbeke G, Molenbergh G. Linear mixed models for longitudinal data. New York: Springer-Verlag; 2000. Verbeke G, Molenbergh G. Linear mixed models for longitudinal data. New York: Springer-Verlag; 2000.
29.
Zurück zum Zitat Fitzmaurice G, Laird N, Ware J. Applied Longitudinal Analysis. Hoboken, NJ: Wiley; 2004. Fitzmaurice G, Laird N, Ware J. Applied Longitudinal Analysis. Hoboken, NJ: Wiley; 2004.
30.
Zurück zum Zitat Diggle PJ, Heagerty P, Liang K, Zeger SL. Analysis of longitudinal data. New York: Oxford University Press; 2002. Diggle PJ, Heagerty P, Liang K, Zeger SL. Analysis of longitudinal data. New York: Oxford University Press; 2002.
31.
Zurück zum Zitat Jensen MD, Ryan DH, Apovian CM, et al. AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2013;2014(129):S102–138. Jensen MD, Ryan DH, Apovian CM, et al. AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2013;2014(129):S102–138.
32.
Zurück zum Zitat Lewis A, Jolly K, Adab P, et al. A brief intervention for weight management in primary care: study protocol for a randomized controlled trial. Trials. 2013;14:393.PubMedCentralCrossRefPubMed Lewis A, Jolly K, Adab P, et al. A brief intervention for weight management in primary care: study protocol for a randomized controlled trial. Trials. 2013;14:393.PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Grant RW, O’Brien KE, Waxler JL, et al. Personalized genetic risk counseling to motivate diabetes prevention: A randomized trial. Diabetes Care. 2013;36:13–19. Grant RW, O’Brien KE, Waxler JL, et al. Personalized genetic risk counseling to motivate diabetes prevention: A randomized trial. Diabetes Care. 2013;36:13–19.
34.
Zurück zum Zitat Vorderstrasse AA, Cho A, Voils CI, Orlando LA, Ginsburg GS. Clinical utility of genetic testing in primary care: The example of type 2 diabetes. Per Med. 2013;10:549–563.CrossRef Vorderstrasse AA, Cho A, Voils CI, Orlando LA, Ginsburg GS. Clinical utility of genetic testing in primary care: The example of type 2 diabetes. Per Med. 2013;10:549–563.CrossRef
35.
Zurück zum Zitat Marteau TM, Weinman J. Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research. Soc Sci Med. 2006;62:1360–1368.CrossRefPubMed Marteau TM, Weinman J. Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research. Soc Sci Med. 2006;62:1360–1368.CrossRefPubMed
36.
Zurück zum Zitat Vassy JL, Shrader P, Jonsson A, et al. Association between parental history of diabetes and type 2 diabetes genetic risk scores in the PPP-Botnia and Framingham Offspring Studies. Diabetes Res Clin Pract. 2011;93:e76–79.PubMedCentralCrossRefPubMed Vassy JL, Shrader P, Jonsson A, et al. Association between parental history of diabetes and type 2 diabetes genetic risk scores in the PPP-Botnia and Framingham Offspring Studies. Diabetes Res Clin Pract. 2011;93:e76–79.PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat de Miguel-Yanes JM, Shrader P, Pencina MJ, et al. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care. 2011;34:121–125.PubMedCentralCrossRefPubMed de Miguel-Yanes JM, Shrader P, Pencina MJ, et al. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care. 2011;34:121–125.PubMedCentralCrossRefPubMed
38.
Metadaten
Titel
Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans
verfasst von
Corrine I. Voils, PhD
Cynthia J. Coffman, PhD
Janet M. Grubber, MSPH
David Edelman, MD, MHS
Azita Sadeghpour, Ph.D., MS
Matthew L. Maciejewski, PhD
Jamiyla Bolton, MS
Alex Cho, MD, MBA
Geoffrey S. Ginsburg, MD, PhD
William S. Yancy Jr., MD, MHS
Publikationsdatum
01.11.2015
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 11/2015
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3315-5

Weitere Artikel der Ausgabe 11/2015

Journal of General Internal Medicine 11/2015 Zur Ausgabe

Healing Arts

Small Talk

Letter to the Editor

CMS Reimbursement Reform

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.